Literature DB >> 16113067

Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats.

Katari A Carello1, Steven E Whitesall, Mary C Lloyd, Scott S Billecke, Louis G D'Alecy.   

Abstract

Elevated plasma concentrations of symmetrical dimethylarginine (SDMA) and asymmetrical dimethylarginine (ADMA) are repeatedly associated with kidney failure. Both ADMA and SDMA can be excreted in urine. We tested whether renal excretion is necessary for acute, short-term maintenance of plasma ADMA and SDMA. Sprague-Dawley rats underwent sham operation, bilateral nephrectomy (NPX), ureteral ligation, or ureteral section under isoflurane anesthesia. Tail-snip blood samples (250 microl) were taken before and at 6- or 12-h intervals for 72 h after operation. Plasma clearance was assessed in intact and NPX rats. High-performance liquid chromatography determined SDMA and ADMA concentrations. Sodium, potassium, creatinine, blood urea nitrogen (BUN), and body weight were also measured. Forty-eight hours after NPX, SDMA increased 25 times (0.23 +/- 0.03 to 5.68 +/- 0.30 microM), whereas ADMA decreased (1.17 +/- 0.08 to 0.73 +/- 0.08 microM) by 38%. Creatinine and BUN increased, paralleling SDMA. Sham-operated animals showed no significant changes. Increased SDMA confirms continuous systemic production of SDMA and its obligatory renal excretion, much like creatinine. In contrast, decreased plasma ADMA suggests that acute total NPX either reduced systemic ADMA formation and/or systemic hydrolysis of ADMA increased 48-h post-NPX. However, plasma clearance of ADMA appeared unchanged 48 h after NPX. We conclude that renal excretory function is needed for SDMA elimination but not needed for acute, short-term ADMA elimination in that systemic hydrolysis is fully capable of clearing plasma ADMA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113067     DOI: 10.1152/ajpheart.00208.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

Review 1.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

Review 2.  Nitric oxide synthase derangements and hypertension in kidney disease.

Authors:  Chris Baylis
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

3.  Evaluation of Renal Biomarkers, Including Symmetric Dimethylarginine, following Gentamicin-Induced Proximal Tubular Injury in the Rat.

Authors:  Diane M Hamlin; A Eric Schultze; Michael J Coyne; Donald J McCrann; Rebekah Mack; Corie Drake; Rachel E Murphy; Julie Cross; Marilyn Strong-Townsend; Maha Yerramilli; Mary K Leissinger
Journal:  Kidney360       Date:  2021-12-07

Review 4.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

5.  Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

Authors:  Scott S Billecke; Louis G D'Alecy; Raylene Platel; Steven E Whitesall; Kenneth A Jamerson; Rachel L Perlman; Crystal A Gadegbeku
Journal:  Nephrol Dial Transplant       Date:  2008-09-15       Impact factor: 5.992

6.  Methylated arginine derivatives in children and adolescents with chronic kidney disease.

Authors:  Ellen R Brooks; Craig B Langman; Sihe Wang; Heather E Price; Abigail L Hodges; Lara Darling; Amy Z Yang; Frederick A Smith
Journal:  Pediatr Nephrol       Date:  2008-10-02       Impact factor: 3.714

Review 7.  Cellular ADMA: regulation and action.

Authors:  Tom Teerlink; Zaiming Luo; Fredrik Palm; Christopher S Wilcox
Journal:  Pharmacol Res       Date:  2009-08-12       Impact factor: 7.658

Review 8.  Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?

Authors:  Ben Caplin; James Leiper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-29       Impact factor: 8.311

9.  Dimethylarginine metabolism during acute and chronic rejection of rat renal allografts.

Authors:  Dariusz Zakrzewicz; Anna Zakrzewicz; Sigrid Wilker; Rolf-Hasso Boedeker; Winfried Padberg; Oliver Eickelberg; Veronika Grau
Journal:  Nephrol Dial Transplant       Date:  2010-07-19       Impact factor: 5.992

10.  Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.

Authors:  Giovanni Li Volti; Salvatore Salomone; Valeria Sorrenti; Andrea Mangiameli; Vincenzo Urso; Ilias Siarkos; Fabio Galvano; Federico Salamone
Journal:  Cardiovasc Diabetol       Date:  2011-07-14       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.